ADAR1 Partners, LP
- SEC CIK
- 0001758866
Latest role at each company
- KROS Keros Therapeutics, Inc.10% Owneras of Oct 15, 2025
- PVLA PALVELLA THERAPEUTICS, INC.10% Owneras of Aug 12, 2024
Trades
Every Form 4 that lists ADAR1 Partners, LP as a reporting owner, including filings made jointly with others. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Company | Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| KROSKeros Therapeutics, Inc. | Oct 15, 20251:24 PM ET | Oct 15, 2025 | ADAR1 Partners, LP and 3 others10% Owner | SSaleCommon Stock | −5.39M | $17.75 | −$95.66M | 0 | −100.0% | SEC |
| KROSKeros Therapeutics, Inc. | Apr 11, 20259:57 PM ET | Apr 9, 2025 | ADAR1 Partners, LP and 3 others10% Owner | PPurchaseCommon Stock | +934.26K | $10.1305 | +$9.46M | 4.39M | +27.0% | SEC |
| PVLAPALVELLA THERAPEUTICS, INC. | Aug 12, 20246:48 PM ET | Aug 9 – Aug 12, 2024 | ADAR1 Partners, LP and 1 other10% Owner | PPurchaseCommon Stock | +6K | $15.3877 | +$92.33K | 15.07K | +66.2% | SEC |